- Home
- ACMR vs QGEN Comparison
ACMR vs QGEN Comparison
Compare ACMR & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACMR | QGEN |
|---|---|---|
| Founded | 1998 | 1986 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 10.2B |
| IPO Year | 2017 | 1998 |
Fundamental Metrics
Financial Performance| Metric | ACMR | QGEN |
|---|---|---|
| Price | $95.32 | $40.05 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $50.00 | $45.76 |
| AVG Volume (30 Days) | 1.8M | ★ 2.2M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 7.17% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.24 | N/A |
| Revenue | ★ $74,643,000.00 | N/A |
| Revenue This Year | $29.37 | $8.18 |
| Revenue Next Year | $23.16 | $5.71 |
| P/E Ratio | $407.58 | ★ $24.01 |
| Revenue Growth | ★ 104.47 | N/A |
| 52 Week Low | $23.03 | $32.53 |
| 52 Week High | $127.19 | $57.82 |
Technical Indicators
Market Signals| Indicator | ACMR | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 50.79 | 65.55 |
| Support Level | $35.32 | $38.80 |
| Resistance Level | N/A | $42.33 |
| Average True Range (ATR) | 9.85 | 0.73 |
| MACD | 0.00 | 0.26 |
| Stochastic Oscillator | 18.34 | 97.99 |
Price Performance
Historical ComparisonAbout ACMR ACM Research Inc.
ACM Research Inc supplies capital equipment developed for the semiconductor industry. The company focuses on developing differentiated process solutions that enable effective particle removal, uniform material deposition, and reliable process control for the fabricators of integrated circuits. Its product offerings include wet-cleaning, plating, furnace, PECVD, track, and other front-end processing equipment. Additionally, it develops, manufactures, and sells a range of packaging equipment to wafer assembly and packaging customers. Geographically, the company generates maximum revenue from its customers in Mainland China, and the rest from other regions.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).